DME

Latest News

October 22nd 2026

Diabetic macular edema: an inflammatory disease in focus

The epidemiology, inflammatory pathophysiology, diagnosis, and treatment of diabetic macular edema are discussed during Inflammatory Eye Disease Week.

October 20th 2026

Duravyu misses wet AMD end point again as EyePoint pivots to DME

By Kassi Filkins

October 15th 2026

EC-104 outperforms Ozurdex in phase 2 BETTIS-1 trial for anti-VEGF–resistant DME

By Martin David Harp

September 8th 2026

Beyond anti-VEGF: A multi-mechanism TKI approach to DME

By Kassi Filkins, Dante Pieramici, MD

August 15th 2026

DURAVYU Phase 3 DME trials COMO and CAPRI complete enrollment

By Kassi Filkins

Video Series

EURETINA 2026: EYP-1901 reduces need for supplemental treatment in phase 2 VERONA study of DME

EURETINA 2026: 2-year SPECTRA results and the phase 3 programme for 4D-150 gene therapy in DMO

What LUGANO and LUCIA could signal for DME: Pieramici on the EYP-1901 program

Shorts

0:59

EYP-1901 positioned as lower-burden option in DME treatment as phase 3 program completes enrollment

2 months ago

by

Kassi Filkins(+1 more)

0:59

The unmet need for long-lasting DME treatment

2 months ago

by

Kassi Filkins(+1 more)

CME Content

Video

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

Video

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH

Video

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

John Kitchens, MD; Michael W. Stewart, MD

Video

MacTel Decoded: Rethinking Conventional Approaches With Novel Neuroprotective Strategies

Charles C. Wykoff MD, PhD; Diana V. Do, MD; Dante Pieramici, MD, FASRS; Jed H. Assam, MD, MS

Video

Treatment Optimization in the Evolving Anti-VEGF Era

Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Dilsher S. Dhoot, MD, FASRS

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

Video

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO

Video

(COPE) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Damon Dierker, OD FAAO; Maria Pribis, OD

Video

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Damon Dierker, OD FAAO; Maria Pribis, OD

Video

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

Mary Qiu, MD; Paul Singh, MD; Danica J. Marrelli, OD, FAAO

Video

(COPE Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

Mary Qiu, MD; Paul Singh, MD; Danica J. Marrelli, OD, FAAO

Video

(CME Track) Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension

Geeta Lalwani, MD; Alla Goldberg, MD; Elite Bor-Shavit, MD

Video

(COPE Track) Next-Generation Solutions for nAMD and DME: Bridging Evidence and Practice Gaps in Disease Management

Murtaza K. Adam, MD, FASRS; Deepak Sambhara, MD, FASRS; Betty Zhang, OD

Video

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

Rahul Tonk, MD; Jade Coats, OD, FAAO; Aaleya Koreishi, MD; Zeba Syed, MD

New therapeutic approaches in the diabetic macular edema pipeline

ByMatt Hoffman

August 12th 2026

Wnt modulators, sustained-release TKIs, and topical steroids are in phase 3 trials for DME, offering alternatives to anti-VEGF injections.

(Modern Retina) Retina World Congress 2026 recap: Durability, diagnosis, and what’s next in retina care

Retina World Congress 2026 recap: Durability, diagnosis, discovery, and what’s next in retina care

ByEye Care Network Staff

July 21st 2026

Presenters highlight clinical insights and lessons from recent trial data and surgical experience

Rethinking OCT biomarkers in DME: Baseline acuity and thickness outperform the rest

ByMichael Ip, MD,Martin David Harp,Kassi Filkins

July 18th 2026

Michael Ip, MD, presented a large-scale analysis of OCT biomarkers in diabetic macular edema (DME), drawing on data from the DRCR Retina Network's Protocol T trial.

Diabetic eye disease: Developments that defined the first half of 2026

ByKassi Filkins

July 13th 2026

A recap of the FDA approvals, phase 3 readouts, and pipeline data that shaped diabetic eye disease care in the first half of 2026.

DME

Latest News

Video Series

EURETINA 2026: EYP-1901 reduces need for supplemental treatment in phase 2 VERONA study of DME

EURETINA 2026: 2-year SPECTRA results and the phase 3 programme for 4D-150 gene therapy in DMO

What LUGANO and LUCIA could signal for DME: Pieramici on the EYP-1901 program

Shorts

CME Content

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

MacTel Decoded: Rethinking Conventional Approaches With Novel Neuroprotective Strategies

Treatment Optimization in the Evolving Anti-VEGF Era

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

(COPE) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(COPE Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(CME Track) Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension

(COPE Track) Next-Generation Solutions for nAMD and DME: Bridging Evidence and Practice Gaps in Disease Management

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

New therapeutic approaches in the diabetic macular edema pipeline

Retina World Congress 2026 recap: Durability, diagnosis, discovery, and what’s next in retina care

Rethinking OCT biomarkers in DME: Baseline acuity and thickness outperform the rest

Diabetic eye disease: Developments that defined the first half of 2026

Trending on Eye Care Network - Ophthalmology Times

Retinal imaging as a window into atrial fibrillation

The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD

Think outside the cone: Applying the Gulani Keratoconus Classification

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

Johnson & Johnson spotlights contrast data, 1 million TECNIS implants, and SmartLOAD delivery